• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15923 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 HAYES, Inc. Preoperative whole-body bathing with chlorhexidine gluconate 4% for prevention of surgical site infection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin glargine (Lantus®) 100 units/ml solution for injection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) C1 inhibitor (Cinryze®) 500 units powder and solvent for solution for injection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Racecadotril (Hidrasec®) 10 mg and 30 mg granules for oral suspension
2013 The Swedish Council on Health Technology Assessment (SBU) [Continuous subcutaneous glucose monitoring for diabetes]
2013 The Swedish Council on Health Technology Assessment (SBU) [Treatment duration for Lyme disease]
2013 The Swedish Council on Health Technology Assessment (SBU) [Emergency care for the elderly patients who are in the poorest health]
2013 The Swedish Council on Health Technology Assessment (SBU) [Urinary incontinence in the elderly]
2013 NIHR Horizon Scanning Centre (NIHR HSC) Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
2013 NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for locally advanced, recurrent or metastatic head and neck squamous cell carcinoma – second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Astuprotimut-r (Zumagev) for stage III, MAGE-A3 positive malignant melanoma – adjuvant therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for HER2-positive breast cancer – adjuvant therapy in combination with or following trastuzumab
2013 NIHR Horizon Scanning Centre (NIHR HSC) LDK378 for ALK-activated advanced non-small cell lung cancer – second and subsequent lines
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed diffuse large B-cell lymphoma
2013 NIHR Horizon Scanning Centre (NIHR HSC) Orteronel for metastatic hormone-relapsed prostate cancer following chemotherapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) TK cell therapy for acute leukaemia patients who are candidate to haematopoietic stem cell transplantation – adjunct therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) POST-C saliva test for suspected oral cancer
2013 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Caris Target Now™ molecular profiling service for solid malignant tumours
2013 NIHR Horizon Scanning Centre (NIHR HSC) AMG 145 for hyperlipidaemia and mixed dyslipidaemia
2013 NIHR Horizon Scanning Centre (NIHR HSC) Cangrelor for prevention of coronary thrombosis in patients undergoing cardiovascular surgery
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) AngelMed Guardian® System for detection of myocardial infarction
2013 NIHR Horizon Scanning Centre (NIHR HSC) Parachute® Implant System for ischaemic heart failure
2013 NIHR Horizon Scanning Centre (NIHR HSC) T30 neurostimulator device for chronic tonal subjective tinnitus
2013 Andalusian Health Technology Assessment Area (AETSA) [Tumor treating fields therapy (TTF) for glioblastoma. A systematic review of the literature]
2013 Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linagliptin (Trajenta®) 5 mg film-coated tablets
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Glycopyrronium bromide (Seebri® Breezhaler®) 44 micrograms inhalation powder as hard capsules
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Aztreonam lysine (Cayston®) 75 mg powder and solvent for nebuliser solution
2013 Penn Medicine Center for Evidence-based Practice (CEP) Urine drug screening in chronic pain patients on opioid therapy
2013 Penn Medicine Center for Evidence-based Practice (CEP) Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on bone fracture healing
2013 Penn Medicine Center for Evidence-based Practice (CEP) Nutrition during hospitalization for pediatric bronchiolitis
2013 Penn Medicine Center for Evidence-based Practice (CEP) Nebulized hypertonic saline treatment for infants with bronchiolitis
2013 Penn Medicine Center for Evidence-based Practice (CEP) Oxygen saturation discharge thresholds for infants admitted with bronchiolitis
2013 Penn Medicine Center for Evidence-based Practice (CEP) Scales for assessing inpatients' risk of accidental falls
2013 Penn Medicine Center for Evidence-based Practice (CEP) Frequently-overused technologies
2013 Penn Medicine Center for Evidence-based Practice (CEP) Routine replacement of peripheral intravenous catheters
2013 Penn Medicine Center for Evidence-based Practice (CEP) Controlled medication agreements for opioid use in chronic pain
2013 Penn Medicine Center for Evidence-based Practice (CEP) Cognitive and procedural skills of aging physicians
2013 Penn Medicine Center for Evidence-based Practice (CEP) Synthetic fleece (Polartec) attire: update
2013 Penn Medicine Center for Evidence-based Practice (CEP) Community health workers
2013 Penn Medicine Center for Evidence-based Practice (CEP) Intravenous or rectal acetaminophen for post-operative pain
2013 Penn Medicine Center for Evidence-based Practice (CEP) Disinfecting caps and antimicrobial locks for reducing blood stream infections associated with central venous catheters
2013 Penn Medicine Center for Evidence-based Practice (CEP) Relationship between hemoglobin A1c levels and complications after elective hip and knee surgery
2013 Penn Medicine Center for Evidence-based Practice (CEP) Esophageal temperature measurement to prevent complications of catheter ablation
2013 Penn Medicine Center for Evidence-based Practice (CEP) Hourly rounding and other interventions to improve patient satisfaction associated with responsiveness
2013 Penn Medicine Center for Evidence-based Practice (CEP) Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2013 Scottish Health Technologies Group (SHTG) Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with melanoma yield clinical and economic benefits?
2013 Scottish Health Technologies Group (SHTG) Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer.
2013 Scottish Health Technologies Group (SHTG) Are silver dressings clinically effective and cost effective for the healing of infected wounds and the prevention of wound infection relative to other types of dressing?
2013 Scottish Health Technologies Group (SHTG) Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with sarcoidosis yield clinical and economic benefits?
2013 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2013 Scottish Health Technologies Group (SHTG) Can wrist splints or steroid injections reduce the need for decompression surgery in carpal tunnel syndrome?
2013 Scottish Health Technologies Group (SHTG) What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2013 Scottish Health Technologies Group (SHTG) What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2013 Scottish Health Technologies Group (SHTG) PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2013 Scottish Health Technologies Group (SHTG) Is patient self-monitoring (including self-testing and self-management) of oral anticoagulation therapy safe, efficacious, and cost effective? (update of EN 27)
2013 Scottish Health Technologies Group (SHTG) What is the evidence for the clinical and cost effectiveness of major trauma centres as the core component of a trauma service, compared with standard care for adults with major trauma?
2013 Scottish Health Technologies Group (SHTG) Is cone beam computed tomography (CBCT) clinically effective, cost-effective and safe compared with standard extraoral and intraoral radiography in the diagnosis of hard tissue pathology in routine dental practice?
2013 Scottish Health Technologies Group (SHTG) What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2013 NIHR Horizon Scanning Centre (NIHR HSC) Eribulin mesilate (Halaven) for advanced non-small cell lung cancer – third line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Olaparib for relapsed platinum-sensitive ovarian cancer
2013 NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) in combination with dexamethasone for multiple myeloma – third line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Darapladib for cardiovascular risk reduction in patients with coronary heart disease – add on therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe and simvastatin (Inegy) for reduction of cardiovascular risk in coronary heart disease
2013 NIHR Horizon Scanning Centre (NIHR HSC) Spectropath Image-Guided Surgery System with Spectropen™ for cancer surgery
2013 NIHR Horizon Scanning Centre (NIHR HSC) Neochord DS1000™ system for mitral valve regurgitation
2013 NIHR Horizon Scanning Centre (NIHR HSC) Eliglustat for Gaucher disease
2013 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (Eylea) for visual impairment due to diabetic macular oedema – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Inflectra (infliximab biosimilar) for ankylosing spondylitis
2013 NIHR Horizon Scanning Centre (NIHR HSC) Inflectra (infliximab biosimilar) for psoriatic arthritis
2013 NIHR Horizon Scanning Centre (NIHR HSC) Odanacatib for male osteoporosis – first and second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) NeuroAD™ for mild and moderate Alzheimer's Disease
2013 NIHR Horizon Scanning Centre (NIHR HSC) Bucelipase-alfa (Kiobrina) for pre-term infants
2013 NIHR Horizon Scanning Centre (NIHR HSC) ICES13 for stress urinary incontinence in women - second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for Shiga-Toxin producing Escherichia coli Haemolytic-Uraemic Syndrome – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) NephroCheck® Test for assessing risk of acute kidney injury
2013 NIHR Horizon Scanning Centre (NIHR HSC) Nintedanib for idiopathic pulmonary fibrosis – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for plaque psoriasis in adolescents
2013 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Music therapy in palliative setting]
2013 National Evidence-based Healthcare Collaborating Agency (NECA) [Cost-effectiveness of human papillomavirus vaccination in South Korea]
2013 National Evidence-based Healthcare Collaborating Agency (NECA) [Prescription patterns and safety of benzodiazepines in Korea]
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hybrid operating room]
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme - Part IX: Evidence-based screening guidelines for pregnant women and children (0 – 6 yrs.)]
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide, MDV3100 (Xtandi®) for patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trastuzumab emtansine (KadcylaTM) for previously treated patients with HER2-positive advanced/metastatic breast cancer
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Aflibercept, AVE0005 (Zaltrap®) for the treatment of patients with relapsed or refractory metastatic colorectal cancer (mCRC)
2013 HAYES, Inc. Autologous stem cell transplantation for crohn's disease
2013 HAYES, Inc. Bioidentical hormone replacement therapy for menopausal symptoms
2013 HAYES, Inc. Capsule endoscopy of the small bowel for obscure gastrointestinal bleeding
2013 HAYES, Inc. Labiaplasty for labia minora hypertrophy
2013 HAYES, Inc. Low-dose helical (spiral) computed tomography for lung cancer screening
2013 HAYES, Inc. Nitric oxide breath analysis for the diagnosis and management of asthma
2013 HAYES, Inc. Recombinant human growth hormone treatment in children under 2 years of age
2013 HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2013 HAYES, Inc. Ultrafiltration in congestive heart failure